Startups
Visikol is focused on accelerating the drug discovery process and reducing therapeutic development costs through leveraging its 3Screen™ tissue imaging and image analysis services to extract actionable insights from tissues.
Overview
Location
United States, New Jersey, Hampton
Employees
11-50
Phone
+1 800-615-8474
Total raised
$725K
Founded date
2016
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Feb 24, 2016 | Funding round | $500K |
Mentions in press and media 17
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Apr 5, 2023 | Today MatTek and Visikol Announce Commercial Integration | HAMPTON, N.J. (PRWEB) April 05, 2023 Today, MatTek CEO Alex Armento and Visikol CEO Michael Johnson, Ph.D., have announced that the two companies will officially be commercial integrating under the MatTek name. Previously, both MatTek and V... |
| Oct 11, 2022 | Standard BioTools Announces Collaboration Agreement With Visikol to Offer Multiplex Imaging Mass Cytometry Services | SOUTH SAN FRANCISCO, Calif. (PRWEB) October 11, 2022 Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health™ – today announced a collaboration agreement with Visikol® for... |
| Jul 28, 2022 | Visikol to Expand Facility to Meet Growing Demand For Services | HAMPTON, N.J. (PRWEB) July 28, 2022 Visikol has announced today that it has expanded its Hampton, NJ facility 11,000 sq ft through the addition of lab space and office space to meet the growing demand from its clients and customers. Visikol... |
| Jun 21, 2022 | Visikol Announces the Launch of Novel Blood Brain Barrier Assay | HAMPTON, N.J. (PRWEB) June 21, 2022 The BBB behaves as a highly selective semipermeable membrane separating circulating blood from the central nervous system while allowing the passage of glucose, water, and amino acids into the cerebrospin... |
| May 13, 2022 | Visikol Commits to Automation in its 3D Cell Culture Center of Excellence | HAMPTON, N.J. (PRWEB) May 13, 2022 Last year, Visikol announced the first of several laboratory expansions and the build out of its 3D Cell Culture Center of Excellence, which is designed to provide clients with best-in-class 3D cell cultur... |
| Mar 14, 2022 | Visikol Partners with Molecular Instruments to Offer Hybridization Chain Reaction (HCR)-RNA FISH Multiplex Tissue Imaging Services | Combining the spatiotemporal patterns of gene expression with protein expression allows Visikol to provide an even greater deal of insights from a single slide, which is incredibly important for precious clinical and preclinical samples,&qu... |
| Sep 21, 2021 | BICO Launches 3D Bioprinting contract research offering from CELLINK, MatTek and Visikol | BICO Launches 3D Bioprinting contract research offering from CELLINK, MatTek and Visikol Tue, Sep 21, 2021 14:00 CET The three companies have joined forces to present customers a first of its kind full-service 3D biomanufacturing and in vit... |
| Jul 6, 2021 | Visikol partners with MatTek to leverage their advanced cell culture models in its suite of drug discovery services | Visikol partners with MatTek to leverage their advanced cell culture models in its suite of drug discovery services Tue, Jul 06, 2021 15:00 CET Over the last two months, both MatTek and Visikol have been acquired by CELLINK, the world’s lea... |
| May 31, 2021 | Visikol Launches DILI 3D Cell Culture Assay Services Using Corning® Qualified 3D PHH Spheroid Assay-Ready Plates | As a company, we have always felt that our model agnostic approach allows us to be truly unbiased in offering our Clients assay solutions and we are excited to enter into the agreement with Corning as we are now able to provide our Clients ... |
Show more
Reviews 0
FAQ about Visikol
When was Visikol founded?
Visikol was founded in 2016.
How much funding has Visikol raised?
Visikol has raised $725K in total across 2 funding rounds.
What funding rounds has Visikol raised?
Parsers VC lists 2 funding rounds of Visikol, among them a funding round of $500K on Feb 24, 2016.
What has the press written about Visikol?
Parsers VC has collected 17 articles mentioning Visikol, among them “Today MatTek and Visikol Announce Commercial Integration” (Apr 5, 2023) and “Standard BioTools Announces Collaboration Agreement With Visikol to Offer Multiplex Imaging Mass Cytometry Services” (Oct 11, 2022).
Is Visikol still active?
Yes, Visikol is active; its latest activity on Parsers VC dates from Apr 30, 2024.